Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Macdonald, D. Nahirney, M. Duszyk (Edmonton, AB, Canada). Transcriptional regulation of the human cystic fibrosis transmembrane conductance regulator gene promoter by peroxisome proliferator-activated receptor γ. Eur Respir J 2007; 30: Suppl. 51, 405

Member's Comments

No comment yet.

Related content which might interest you: Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines Source: Eur Respir J 2005; 26: Suppl. 49, 97s Year: 2005 Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Source: Eur Respir J 2007; 30: 245-252 Year: 2007 Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ Source: Eur Respir J 2006; 28: Suppl. 50, 229s Year: 2006 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir Rev 2006; 15: 211-212 Year: 2006 The effect of peroxisome proliferator-activated receptor-? ligands on in vitro and in vivo models of COPD Source: Eur Respir J 2014; 43: 409-420 Year: 2013 The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006 Involvement of C/EBPbeta and delta in lung glucocorticoid signaling Source: Eur Respir J 2002; 20: Suppl. 38, 372s Year: 2002 The effects of exercise training on peroxisome proliferator-activated receptor (PPAR) expression in skeletal muscle in COPD Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation Year: 2009 Relationship between peroxisome proliferator-activated receptor α and neutrophils in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 452s Year: 2004 Regulation of eotaxin gene transcription by peroxisome proliferator-activated receptor γ agonists in human airway smooth muscle cells: interactions with glucocorticoids and β2-agonists Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005 The role of peroxisome proliferator-activated receptor γ in pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Role of exogenous ligands for the peroxisome proliferator-activated receptor-β/δ in the development of bleomycin-induced lung injury Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Impacts of peroxisome proliferator-activated receptor gamma activation on cigarette smoke-induced exacerbated response to bacteria Source: Eur Respir J 2015; 45: 191-200 Year: 2015 Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Source: Eur Respir J 2008; 31: 502-508 Year: 2008 Role of peroxisome proliferator activated receptor γ in COPD Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 The pattern recognition receptor Nod1 activates CCAAT/enhancer binding protein β signalling in lung epithelial cells Source: Eur Respir J 2007; 30: 214-222 Year: 2007 Muscarinic receptor stimulation differentially regulates extracellular matrix gene expression in lung fibroblasts Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 The inhibitory effect of peroxisome proliferator-activated receptor-γ ligands on malignant pleural mesothelioma cell growth Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008